Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Raw Materials (2016 - 2025)

STRATA Skin Sciences' Raw Materials history spans 10 years, with the latest figure at $2.9 million for Q3 2025.

  • For Q3 2025, Raw Materials rose 20.29% year-over-year to $2.9 million; the TTM value through Sep 2025 reached $2.9 million, up 20.29%, while the annual FY2024 figure was $2.0 million, 6.89% down from the prior year.
  • Raw Materials for Q3 2025 was $2.9 million at STRATA Skin Sciences, down from $3.2 million in the prior quarter.
  • Across five years, Raw Materials topped out at $5.8 million in Q3 2023 and bottomed at $2.0 million in Q4 2024.
  • The 5-year median for Raw Materials is $3.0 million (2022), against an average of $3.4 million.
  • The largest annual shift saw Raw Materials skyrocketed 79.43% in 2022 before it plummeted 58.53% in 2024.
  • A 5-year view of Raw Materials shows it stood at $3.2 million in 2021, then dropped by 7.34% to $3.0 million in 2022, then decreased by 26.1% to $2.2 million in 2023, then dropped by 6.89% to $2.0 million in 2024, then skyrocketed by 41.45% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Raw Materials are $2.9 million (Q3 2025), $3.2 million (Q2 2025), and $2.5 million (Q1 2025).